In B cells, Gal-9 deficient mice are reported to have increased B cell proliferation, enlarged GCs, and stronger Ab responses to infection, and Gal-9 treatment has been observed to inhibit vaccination-induced antibody responses and ameliorate pathology in mouse models of systemic lupus erythematosus17–20,23. This evidence concerns the gene LGALS9 and infection.